Recombinant Human MTMR7 Protein ，His & SUMO

MTMR7 (Myotubularin-related protein 7) is a member of the myotubularin family, which is characterized by its lipid phosphatase activity involved in the regulation of phosphoinositides, critical for various cellular processes, including membrane trafficking and cytoskeletal dynamics. Mutations in the MTMR7 gene are associated with human disorders, particularly Charcot-Marie-Tooth disease type 4B (CMT4B), a hereditary neuropathy that leads to progressive muscle weakness and atrophy. The study of MTMR7 recombinant protein has gained significant interest as understanding its enzymatic properties and interactions can provide insights into the pathogenesis of CMT4B and other related conditions. Research has focused on characterizing the protein's structure, function, and the impact of specific mutations on its activity, which are crucial for developing therapeutic interventions. Moreover, examining MTMR7's role in phosphoinositide metabolism can illuminate its broader involvement in cellular signaling pathways and its potential implications in neurodegenerative diseases. By producing recombinant MTMR7, scientists aim to facilitate structure-function studies and high-throughput screening for small molecules that could modulate its activity, ultimately leading to novel therapeutic strategies for patients affected by MTMR7-related disorders. As our understanding of MTMR7 evolves, it poses significant potential for advancing treatments for inherited neuropathies and enhancing our knowledge of cellular mechanisms underlying these complex diseases.